Studies eligible for co-enrolment with OPTIMISE II

Effective 2nd April 2019

  • Add Aspirin Trial

    • A phase III, double blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non metastatic solid tumours. ISRCTN: 74358648
  • The CIPHER Study

    • UK Cohort study to Investigate the prevention of Parastomal Hernia (Phase B). ISRCTN: 17573805
  • PQIP

    • National Perioperative Quality Improvement Programme to measure care delivered, complications and outcome from the patient perspective after major surgery.
  • The ROCKet Trial

    • Reduction of Chronic Post-surgical Pain with Ketamine - phase 3/4 randomised controlled trial of the effect of up to 72 hours of perioperative ketamine on the risk of development of chronic post-surgical pain.
  • WesFit

    • To investigate the efficacy of a community based Structured Responsive Exercise-training Programme (SRETP) ± psychological support on surgical outcome by reducing postoperative length of stay (LOS) and complications. Identifier: NCT03509428

    • Cohort study to investigate whether giving patients intravenous iron improves their fitness. Identifier: NCT03346213
  • GAP Study

    • Gabapentin in postsurgical pain. ISRCTN: 63614165
  • INTACT Study

    • A feasibility, open-label, randomised controlled trial of intravenous iron versus usual care in survivors of intensive care with moderate and severe anaemia. ISRCTN: 13721808